MarketCap
Facebook
X
Telegram
Acutus Medical Net Income | AFIB
Net profit is a financial indicator that reflects the remaining amount of money after deducting all expenses and taxes from the company’s total income over a certain period of time. It is one of the key indicators of a company’s financial stability and success.
Net profit is the portion of total profit remaining after taxes and depreciation have been deducted.[1]
It is the result of a company’s operations and reflects its efficiency in managing resources, controlling expenses, and generating income. It includes all operating revenues and expenses, such as sales of goods or services, production costs, administrative expenses, taxes, and other financial metrics.
The calculation of net profit includes the deduction of all necessary expenses such as employee salaries, rent, utilities, taxes, and other mandatory payments. After all these expenses are deducted from the total income, the remaining amount is considered the company’s net profit.
Net profit is an important indicator of a company’s financial health, as it reflects its ability to generate earnings and manage its finances. High net profit indicates business success, competitiveness, and efficiency in resource utilization. It also allows a company to invest in its development, pay dividends to shareholders, or create reserve funds for unforeseen situations.
It serves as a basis for calculating other financial indicators, such as return on sales, return on assets, or return on equity. It is also used to assess the performance of management and make decisions regarding the future development of the company.
However, it should be noted that net profit can be affected by various factors, such as economic conditions, changes in legislation, market competition, and other external influences. Therefore, companies must be prepared for possible changes and take measures to ensure the stability of their financial results.
Annual Net Income Acutus Medical
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -9.55 M | -81.7 M | -39.6 M | -118 M | -102 M | -97 M | -47.9 M | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -9.55 M | -118 M | -70.8 M |
Quarterly Net Income Acutus Medical
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -5.61 M | -914 K | -1.62 M | - | -13.2 M | -18.3 M | -16.3 M | - | -20.4 M | 5.72 M | -40 M | - | -28.5 M | -28.7 M | -29.2 M | - | -31.3 M | -23.2 M | -18.1 M | - | -32.1 M | -30.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 5.72 M | -40 M | -19.5 M |
References
- Bhamornsiri, S., & Wiggins, C. (2001). Comprehensive income disclosures. The CPA Journal, 71(10), 54.
Net Income of other stocks in the Medical devices industry
| Issuer | Net Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Orthofix Medical
OFIX
|
-92.2 M | $ 9.74 | -1.12 % | $ 386 M |  Curacao |
 |
TransMedics Group
TMDX
|
190 M | $ 72.4 | -3.14 % | $ 2.46 B |  USA |
 |
Alphatec Holdings
ATEC
|
-143 M | $ 10.86 | -0.41 % | $ 1.63 B | USA |
 |
Bruker Corporation
BRKR
|
-8.3 M | $ 59.11 | 5.68 % | $ 8.97 B | USA |
 |
Abbott Laboratories
ABT
|
6.52 B | $ 100.51 | -2.1 % | $ 175 B | USA |
 |
Cytosorbents Corporation
CTSO
|
-8.2 M | $ 5.35 | 0.56 % | $ 333 M | USA |
 |
Nevro Corp.
NVRO
|
-113 M | - | - | $ 217 M | USA |
 |
Electromed
ELMD
|
11.3 M | $ 27.32 | -0.44 % | $ 226 M | USA |
 |
Establishment Labs Holdings
ESTA
|
-51.1 M | $ 62.28 | 1.98 % | $ 1.84 B |  Costa-rica |
 |
Venus Concept
VERO
|
-47 M | - | - | $ 726 K | USA |
 |
Helius Medical Technologies
HSDT
|
-40.9 M | $ 2.36 | 1.29 % | $ 52 M | USA |
 |
Eargo
EAR
|
-157 M | - | - | $ 10.2 M | USA |
 |
Sientra
SIEN
|
-22 M | - | -16.59 % | $ 10.3 M | USA |
 |
Silk Road Medical, Inc
SILK
|
-55.7 M | - | - | $ 1.07 B | USA |
 |
Integer Holdings Corporation
ITGR
|
103 M | $ 126.7 | -0.04 % | $ 4.4 B | USA |
 |
Aethlon Medical
AEMD
|
-7.15 M | $ 5.07 | -4.52 % | $ 3.42 M | USA |
 |
Surgalign Holdings
SRGA
|
-54.6 M | - | -32.98 % | $ 1.68 M | USA |
 |
ShockWave Medical
SWAV
|
147 M | - | - | $ 12.3 B | USA |
 |
Abiomed
ABMD
|
137 M | - | - | $ 17.2 B | USA |
 |
Titan Medical
TMDI
|
-14.9 M | - | -26.32 % | $ 19.6 M |  Canada |
 |
Natus Medical Incorporated
NTUS
|
13.2 M | - | 1.94 % | $ 1.05 B | USA |
 |
Cardiovascular Systems
CSII
|
-36.9 M | - | 0.15 % | $ 844 M | USA |
 |
Inari Medical
NARI
|
-1.64 M | - | - | $ 4.23 B | USA |
 |
Allied Healthcare Products
AHPI
|
-1.94 M | - | 3.58 % | $ 2.21 M | USA |
 |
Avinger
AVGR
|
-18.3 M | - | -20.74 % | $ 369 K | USA |
 |
Apollo Endosurgery
APEN
|
-39.8 M | - | - | $ 475 M | USA |
 |
NuVasive
NUVA
|
40.4 M | - | - | $ 2.07 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
-6.09 M | - | - | $ 3.31 B | USA |
 |
ThermoGenesis Holdings
THMO
|
-18.9 M | - | -25.84 % | $ 171 K | USA |
 |
Talis Biomedical Corporation
TLIS
|
-62 M | - | 3.55 % | $ 7.96 M | USA |
 |
Viveve Medical
VIVE
|
-22 M | - | -15.35 % | $ 1.71 M | USA |
 |
ViewRay
VRAY
|
-107 M | - | 1.54 % | $ 468 M | USA |
 |
SmileDirectClub
SDC
|
-86.4 M | - | -53.45 % | $ 9.71 M | USA |
 |
BIOLASE
BIOL
|
-20.6 M | - | -13.19 % | $ 166 K | USA |
 |
Vapotherm
VAPO
|
-58.2 M | - | 6.72 % | $ 34 M | USA |
 |
LivaNova PLC
LIVN
|
-242 M | $ 78.44 | -1.59 % | $ 4.28 B |  Britain |
 |
LENSAR
LNSR
|
-34.3 M | $ 5.69 | -2.07 % | $ 68 M | USA |
 |
SeaSpine Holdings Corporation
SPNE
|
-54.3 M | - | 0.28 % | $ 270 M | USA |
 |
Accuray Incorporated
ARAY
|
-49.2 M | $ 0.14 | -3.52 % | $ 17.2 M | USA |
 |
Pulmonx Corporation
LUNG
|
-54 M | $ 1.83 | 0.55 % | $ 74.5 M | USA |
 |
Zynex
ZYXI
|
2.99 M | - | - | $ 21.1 M | USA |
 |
Conformis
CFMS
|
-50.5 M | - | - | $ 16.4 M | USA |
 |
Medigus Ltd.
MDGS
|
4.05 M | - | 10.28 % | $ 55.5 M |  Israel |
 |
Align Technology
ALGN
|
410 M | $ 151.37 | 0.58 % | $ 11 B | USA |
 |
Apyx Medical Corporation
APYX
|
-11.2 M | $ 2.51 | 2.87 % | $ 103 M | USA |
 |
Boston Scientific Corporation
BSX
|
2.89 B | $ 44.51 | -2.38 % | $ 65.9 B | USA |
 |
Bio-Rad Laboratories
BIO
|
760 M | $ 360.5 | 1.79 % | $ 9.83 B | USA |
 |
ClearPoint Neuro
CLPT
|
-25.5 M | $ 9.25 | -2.12 % | $ 262 M | USA |
 |
Cutera
CUTR
|
-57.2 M | - | -10.19 % | $ 1.99 M | USA |